Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

CSL Limited (ASX:CSL): What Do FY26 Impairments and Plasma Operations Reveal?

CSL (ASX:CSL) operates through CSL Behring, CSL Seqirus and CSL Vifor. Behring develops and markets therapies for immunodeficiency, bleeding disorders and other serious conditions, drawing on plasma collection and specialist manufacturing. Seqirus supplies influenza vaccines, while Vifor covers medicines including products addressing iron deficiency. …

Aditi Sarkar | 12 November 2026

Sigma Healthcare (ASX:SIG): Chemist Warehouse Merger Shapes FY26 Earnings

Sigma Healthcare (ASX:SIG) combines consumer-facing pharmacy retail activities with wholesale distribution and related services to pharmacies. The Chemist Warehouse network is an important element of its retail exposure, while distribution operations support theSupplyof pharmaceutical and health products. The business is principally active in Australia …

Aditi Sarkar | 12 November 2026

Fisher & Paykel Healthcare (ASX:FPH): Hospital Products Lift FY26 Revenue

Fisher & Paykel Healthcare (ASX:FPH) supplies products to hospitals and for home-based respiratory treatment. Its Hospital product group covers humidification, respiratory support and products associated with acute and surgical care. The other principal area addresses obstructive sleep apnoea through masks and related equipment. Sales …

Aditi Sarkar | 12 November 2026

Pro Medicus (ASX:PME): FY26 Imaging Contracts and Profit Measures Explained

Pro Medicus (ASX:PME) develops healthcare information technology, including the Visage imaging platform, for customers such as hospitals and radiology providers. Its software supports the viewing and workflow of medical images and related information, with implementations taking place through contracts with healthcare institutions. Commercial outcomes …

Aditi Sarkar | 12 November 2026

Resmed (ASX:RMD): Sleep Devices and FY27 First-Quarter Revenue Trends

Resmed (ASX:RMD) supplies positive airway pressure devices, masks and accessories for sleep-related breathing disorders. ItsBusinessalso includes residential-care software, with customers and users located internationally. The sale of a device is different from subsequent purchases of masks and related accessories, while software revenue follows its …

Aditi Sarkar | 12 November 2026

Ramsay Health Care (ASX:RHC): FY26 Hospital Earnings and the Proposed Santé Demerger

Ramsay Health Care (ASX:RHC) reports activities spanning Australian hospitals, the Ramsay UK acute hospital business, Elysium mental healthcare in the UK and Ramsay Santé in continental Europe. Performance varies between these operations because patient volumes, reimbursement arrangements, staffing requirements and hospital capacity differ by …

Aditi Sarkar | 12 November 2026

Cochlear (ASX:COH): What FY26 Implant Sales Reveal About the Nexa Rollout

Cochlear (ASX:COH) reports three principal product groupings: cochlear implants, Services and Acoustics. Implant systems address severe to profound hearing loss, while Services includes replacement sound processors, accessories and related products. Acoustics includes implantable bone-conduction solutions. The group serves developed and emerging healthcare markets, where …

Aditi Sarkar | 12 November 2026

Sonic Healthcare (ASX:SHL): FY26 Pathology Revenue, Earnings and Cash Flow

Sonic Healthcare (ASX:SHL) operates clinical laboratories in Australia, Europe, New Zealand and North America alongside radiology and medical-centre activities. Pathology services include processing clinical specimens and reporting laboratory findings to referring clinicians. Radiology services involve diagnostic imaging. The group also operates Australian medical centres …

Aditi Sarkar | 12 November 2026

Ansell (ASX:ANN): FY26 Protective Equipment Earnings and FY27 Guidance

Ansell (ASX:ANN) reports Healthcare and IndustrialBusinesssegments. Healthcare products include surgical, examination and single-use gloves and cleanroom protection, while the Industrial segment offers mechanical and chemical protection solutions. Customers include healthcare providers and workplaces requiring specialist protection from hazards. The group’s internationalManufacturingand distribution activities create …

Aditi Sarkar | 12 November 2026

Telix Pharmaceuticals (ASX:TLX): Q3 2026 Revenue and Radiopharmaceutical Milestones

Telix Pharmaceuticals (ASX:TLX) operates commercial molecular-imaging products and research programs focused on targeted radiopharmaceutical therapies. Its prostate-specific membrane antigen positron emission tomography imaging portfolio includes Illuccix and Gozellix. The company also operatesManufacturingand distribution capabilities through Telix Manufacturing Solutions. Commercial sales depend on product authorisations, …

Aditi Sarkar | 12 November 2026
Support

Hi! How can we help you today?

Loading…